October 5, 2026 · Gut · DOI: 10.1136/gutjnl-2026-338178

Microbiota-host genetic interactions modulate MASLD risk in <em>PNPLA3<sup>I148M</sup></em> carriers via ceramides and are reversible by targeted microbial interventions

Listen to this summary

The authors investigate how disruptions in the intestinal host-microbiota interface influence the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) in carriers of the PNPLA3 I148M variant. Their findings reveal that impaired gut barrier function exacerbates hepatic injury through increased levels of microbiota-associated metabolites, suggesting that targeting the microbiota could be a viable strategy to mitigate MASLD progression in genetically susceptible individuals.

Madhuri Haque, Till Robin Lesker, Ulrike Rolle-Kampczyk, Anneleen Segers, Willem M De Vos, Antonio Molinaro, Thriveni Basavanapura, Yazhou Chen, Maria Backhaus, Mohamed Ramadan Mohamed, Lu Jiang, Qusay Salih, Lena Candels, Marcus Henricsson, Agata Bielecka, Sonja Lang, Frank Tacke, Jan G Hengstler, Carolin Victoria Schneider, Münevver Demir, Till Strowig, Martin von Bergen, Kai Markus Schneider, Christian Trautwein

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play